Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • ACT Tulsa
  • Contact

Lab to market

    Home Entrepreneur Lab to market
    NextPrevious

    Lab to market

    By admin | Entrepreneur, News, SeedStep Angels | Comments are Closed | 25 March, 2013 | 0

    By Heide Brandes

    OKCBiz

    Copyright © 2013, Parkway Publishing LLC, All Rights Reserved

    In a lab at Oklahoma Medical Research Foundation, scientists are cloning antibodies.

    Funded by the newly formed Accele Biopharma Business Accelerator, a startup company is learning to use vaccines to strip DNA from antibodies in order to feed that DNA into specific germs. Those germs then spit out copies of the antibodies.

    Whereas in the past, antibodies had to be replicated in mice, this new technology shaves off a year (not to mention hundreds of thousands of dollars) of work in cloning antibodies.

    Click here to read the article at the OKCBiz website.

    Accele Biopharma

    NextPrevious
    i2E-300dpi-Trans-Light
    • Events
    • News
    • Resources
    • Media
    • Love’s Cup

    Oklahoma City Office

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305
    Click HERE for printable map with directions.

    Tulsa Office

    100 S. Cincinnati Ave – 5th Floor, Suite 514
    Tulsa, OK 74103
    PHONE 918/582-5592
    Copyright 2022 i2E, Inc. | All Rights Reserved
    • About
    • Entrepreneurship
      • Venture Advisory Services
      • Love’s Entrepreneur’s Cup
      • ACT Tulsa
    • e3
    • Concept Fund
    • Portfolio
    • iMCI
    • ACT Tulsa
    • Contact
    i2E